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Background and aims: Evidence based medicine and quality control systems 
drive diabetes care, but room for improvement, not only in glycemic control, 
but also in follow up of other outcome and process indicators, exists. In the 
present study we examine how glycemic control is related to other outcome 
and process indicators. 
Materials and methods: We used the 2009 data from a Belgian quality assurance 
study that has been carried out since 2001 in all hospital-based diabetes 
centres (n=113) and provides data (demographics, blood glucose control, 
cardiovascular risk status, diabetes complications, self-monitoring, and drug 
treatment) on a cross-sectional random 10% sample of the adult type 1 and 
type 2 diabetes patients on ≥ 2 daily insulin injections. Logistic regression 
analysis was used to examine the relationship of HbA1c with 5 process and 5 
outcome indicators, while adjusting for age, diabetes duration and gender. 
Results: In the type 1 diabetes population (n=3407; 57% males) the median 
age, diabetes duration and HbA1c were 47 years, 17 years and 7.8%, respectively. 
In the type 2 diabetes population (n=7879; 49% males) the median age, 
diabetes duration and HbA1c were 69 years, 14 years and 7.5%, respectively. 
Table 1 shows the performance in terms of process and intermediate outcome 
by HbA1c and diabetes type (Table legend: (1) p<0.05; (2) p<0.01; (3) 
p<0.001: Results from logistic regression analysis, after adjustment for age, 
gender and diabetes duration. HbA1c < 7% is used as reference.). Especially 
in type 2 and to a minor extent in type 1 diabetes, patients with the worst 
glycemic control (HbA1c ≥ 9%) were significantly less likely to be screened 
for complications (except for microalbuminuria screening) than the patients 
with optimal glycemic control (HbA1c < 7%). In both diabetes types, patients 
with suboptimal glycemic control (HbA1c ≥ 7%) were significantly less 
likely to reach blood pressure and blood lipid targets compared to patients 
with optimal glycemic control. Moreover in type 1 diabetes the proportion 
of smokers increased significantly with increasing HbA1c. These results were 
independent of age, diabetes duration and gender. 
Conclusion: Quality of care in this population of diabetes patients with advanced 
disease stage was relatively good in terms of process and intermediate 
outcome. However suboptimal glycemic control was found to go hand in 
hand with poorer results for both other outcome and process indicators. The 
identification of patients characterised by this cluster of poor performance 
and of the causal factors merits further investigation  
 
Table 1: Performance rates by HbA1c and type of diabetes 
 HbA1c 








% Screening microalbuminuria 89 88 88 87 
% Eye examination 85 87 87 80(2)
% Foot sensation examination  88 87 85 84 
% Foot pulses examination 88 89 91 88 
% ≥ 3 HbA1c determinations/year 68 75(1) 70 60(2)
% Blood pressure < 130/80 mmHg 40 32(2) 33(1) 32(1)
% LDL < 100 mg/dl 63 59 52(2) 49(2)
% Cholesterol < 175 mg/dl 53 45(1) 42(2) 36(3)
% BMI < 25 kg/m² 52 45 45 46 
% non-smoking 84 82(1) 77(3) 67(3)








% Screening microalbuminuria 86 86 84 82 
% Eye examination 83 82 84 76(3)
% Foot sensation examination  81 81 81 77(3)
% Foot pulses examination 87 88 88 85(1)
% ≥ 3 HbA1c determinations/year 57 60 57 48(3)
% Blood pressure < 130/80 mmHg 24 21(2) 19(3) 20(2)
% LDL < 100 mg/dl 65 66 62(1) 53(3)
% Cholesterol < 175 mg/dl 60 58(1) 55(3) 46(3)
% BMI < 25 kg/m² 15 13 13 12 
% non-smoking 88 87 87 83 
(1) p<0.05; (2) p<0.01; (3) p<0.001: Results from logistic regression analysis, after 
adjustment for age, gender and diabetes duration. HbA1c < 7% is used as reference 
 
 
 
